香草酸对链脲佐菌素诱导的糖尿病大鼠的肾保护作用。
Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats.
作者信息
Kumari Savita, Kamboj Anjoo, Wanjari Manish, Sharma Anil Kumar
机构信息
Department of Pharmacology, IKG-PTU (Punjab Technical University), Jalandhar, Kapurthala, 144603 Punjab India.
Department of Pharmacology, CT Institute of Pharmaceutical Sciences, Shahpur, Jalandhar, Punjab India.
出版信息
J Diabetes Metab Disord. 2021 Apr 3;20(1):571-582. doi: 10.1007/s40200-021-00782-7. eCollection 2021 Jun.
PURPOSE
To investigate the protective effect of vanillic acid (VA) in streptozotocin (STZ)-induced diabetic nephropathy (DN) in rats.
METHODS
Experimental diabetes mellitus in rats was induced by intraperitoneally administration of single dose of STZ (55 mg/kg). The animals were divided into 5 groups viz., normal control, diabetic control, glimepiride (0.5 mg/kg, orally) and VA treatment (50 and 100 mg/kg, orally) groups. The treatment was started after the confirmation of hyperglycemia (> 250 mg/dl) and continued for 6 weeks. Serum glucose level, and body weight were measured weekly. At the end of study, HbA1c in whole blood, insulin, lipid profile, urea, creatinine and albumin in serum. Creatinine and albumin were measured in urine along with creatinine clearance. In addition, kidney weight and histopathology were assessed.
RESULTS
Treatment with VA markedly attenuated STZ-induced body weight loss and hyperglycemia, along with improved lipid profile and HbA1c, without significant alteration of serum insulin levels. It also decreased urea, creatinine and increased albumin in serum. Moreover, VA, significantly reduced urine volume, urinary albumin along with marked improvement in creatinine clearance. Further, the VA treatment significantly reverse the raised levels of oxidative stress markers, pro-inflammatory and fibrotic markers viz. TNF-α, IL-1β, IL-6, TGF-β1 and NFκB activity in kidney tissue. These effects are associated with amelioration of histopathological alterations compared to diabetic control rats. While glimepiride produced similar antihyperglycemic effect but the effect on albuminuria, oxidative stress markers and cytokine levels were less significant as compared to VA (100 mg/kg).
CONCLUSIONS
In conclusion, VA exhibited nephroprotective effect through amelioration of kidney dysfunction and damage in diabetic rats. The observed nephroprotective effect of VA may be ascribed to inhibition of hyperglycemia induced oxido-inflammatory stress and necroptosis of renal tissue possibly due to its antihyperglycemic, antioxidant and anti-inflammatory actions.
目的
研究香草酸(VA)对链脲佐菌素(STZ)诱导的大鼠糖尿病肾病(DN)的保护作用。
方法
通过腹腔注射单剂量STZ(55mg/kg)诱导大鼠实验性糖尿病。将动物分为5组,即正常对照组、糖尿病对照组、格列美脲(0.5mg/kg,口服)组和VA治疗(50和100mg/kg,口服)组。在确认血糖升高(>250mg/dl)后开始治疗,并持续6周。每周测量血清葡萄糖水平和体重。在研究结束时,检测全血糖化血红蛋白(HbA1c)、胰岛素、血脂谱、血清尿素、肌酐和白蛋白。同时检测尿肌酐、白蛋白以及肌酐清除率。此外,评估肾脏重量和组织病理学。
结果
VA治疗显著减轻了STZ诱导的体重减轻和高血糖,改善了血脂谱和HbA1c,而血清胰岛素水平无显著变化。它还降低了血清尿素、肌酐并增加了白蛋白。此外,VA显著减少尿量、尿白蛋白,并显著改善肌酐清除率。此外,VA治疗显著逆转了肾脏组织中氧化应激标志物、促炎和纤维化标志物(即肿瘤坏死因子-α、白细胞介素-1β、白细胞介素-6、转化生长因子-β1和核因子κB活性)的升高水平。与糖尿病对照大鼠相比,这些作用与组织病理学改变的改善有关。虽然格列美脲产生了类似的降血糖作用,但与VA(100mg/kg)相比,其对蛋白尿、氧化应激标志物和细胞因子水平的影响较小。
结论
总之,VA通过改善糖尿病大鼠的肾功能障碍和损伤表现出肾保护作用。VA观察到的肾保护作用可能归因于其对高血糖诱导的氧化炎症应激的抑制以及肾组织坏死性凋亡,这可能与其降血糖、抗氧化和抗炎作用有关。